| 26.09 12:31 | EQS-News: Gerresheimer, Stevanato Group und SCHOTT Pharma schließen strategische 'Alliance for RTU' |
| 26.09 12:31 | EQS-News: Gerresheimer, Stevanato Group und -2- |
| 26.09 12:31 | EQS-News: Gerresheimer, Stevanato Group and SCHOTT Pharma Announce Strategic Industry "Alliance for RTU" |
| 26.09 12:30 | dpa-AFX: EQS-News: Gerresheimer, Stevanato Group und SCHOTT Pharma schließen strategische 'Alliance for RTU' (deutsch) |
| 26.09 12:30 | dpa-AFX: EQS-News: Gerresheimer, Stevanato Group and SCHOTT Pharma Announce Strategic Industry 'Alliance for RTU' (english) |
| 26.09 12:30 | dpa-AFX: EQS-News: Gerresheimer, Stevanato Group und SCHOTT Pharma schließen strategische 'Alliance for RTU' (deutsch) |
| 26.09 12:30 | dpa-AFX: EQS-News: Gerresheimer, Stevanato Group and SCHOTT Pharma Announce Strategic Industry "Alliance for RTU" (english) |
| 26.09 12:30 | EQS-News: Gerresheimer, Stevanato Group und SCHOTT Pharma schließen strategische 'Alliance for RTU' (deutsch) |
| 26.09 12:30 | EQS-News: Gerresheimer, Stevanato Group and SCHOTT Pharma Announce Strategic Industry "Alliance for RTU" |
| 26.09 12:30 | EQS-News: Gerresheimer, Stevanato Group und SCHOTT Pharma schließen strategische 'Alliance for RTU' |
| 26.09 12:30 | EQS-News: Gerresheimer, Stevanato Group und -2- |
| 25.09 08:53 | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution |
| 25.09 08:53 | EQS-PVR: Gerresheimer AG: Release according to -2- |
| 25.09 08:52 | dpa-AFX: EQS-Stimmrechte: Gerresheimer AG (english) |
| 25.09 08:52 | dpa-AFX: EQS-Public Voting Rights: Gerresheimer AG (english) |
| 25.09 08:52 | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution |
| 25.09 08:52 | EQS-PVR: Gerresheimer AG: Release according to -2- |
| 25.09 08:00 | dpa-AFX: ANALYSE-FLASH: JPMorgan belässt Gerresheimer auf 'Overweight' - Ziel 121,80 Euro |
| 25.09 08:00 | dpa-AFX: JPMorgan belässt Gerresheimer auf 'Overweight' - Ziel 121,80 Euro |
| 23.09 11:38 | dpa-AFX: ANALYSE-FLASH: Warburg Research senkt Ziel für Gerresheimer - 'Buy' |
|
|
